Nexaph uses Janoshik Analytical for third-party testing and publishes results at nexaph.com/lab-result/, with a dedicated COA portal at nexaph.coa.swiftcs.ai searchable by lot number. NXP-prefix batch identifiers provide a structured traceability format. An age-gate on the main site is a checkbox confirmation rather than a real account requirement, leaving the COA library effectively publicly accessible. The score is constrained by several gaps: no company name, founders, or team is disclosed anywhere on the site; Finnrick and third-party review sources trace the vendor across multiple domain variants with no public explanation; the refund policy requires researchers to submit independent laboratory proof before a quality claim can be considered; and one publicly documented independent test returned 70% purity on a product the vendor claims at 99%. Finnrick tracks 265 tests across 11 products with a median purity of 99.7% on passing samples - but the 70% outlier, and the vendor-controlled selection of which Janoshik results are made public, are meaningful caveats.
| Dimension | Max | Notes | Score |
|---|---|---|---|
| Third-Party Testing Practice | 30 | Janoshik Analytical named as primary testing lab. HPLC and mass spectrometry confirmed. Janoshik publishes results publicly with verifiable task IDs, enabling cross-check independent of the vendor. Finnrick tracks 265 tests across 11 products with a median purity of 99.7% on passing samples. Deductions applied for: (1) vendor-controlled Janoshik publication model - the vendor selects which batch results go public, meaning a researcher cannot independently verify all batches were tested; (2) one publicly documented independent test returning 70% purity on a product claimed at 99%, raising questions about batch consistency or selective testing; (3) possible link to Chinese pharmaceutical sourcing per published third-party analysis. | 18/30 |
| Batch Traceability & Verification | 20 | NXP-prefix batch identifiers confirmed across vials and COAs. COA portal at nexaph.coa.swiftcs.ai is searchable by lot number. Janoshik task IDs enable cross-verification through Janoshik's own public database. Specific batch examples publicly confirmed (e.g., CJC0503312025-01). Deduction for fragmented domain infrastructure - the vendor operates across nexaph.com, nexaphresearch.com, nexaphpeptide.com, and nexaph.store with no public explanation of which entity owns or fulfills the product. | 15/20 |
| COA Accessibility | 15 | Public lab results page at nexaph.com/lab-result/ accessible via a checkbox age-gate (not a real account requirement). COA portal at nexaph.coa.swiftcs.ai dedicated to lot-level lookup. Janoshik task IDs on COAs provide an independent verification path through Janoshik's own archive. Gallery/portal format is functional. Minor deduction for the distinction between the gallery page and a fully browseable lot-indexed archive. | 11/15 |
| COA Completeness | 15 | HPLC and mass spectrometry via Janoshik confirmed. Janoshik's standard service covers purity and identity. No publicly documented sterility, endotoxin, or heavy metal panels in the standard batch offering. | 9/15 |
| Testing Recency | 10 | Finnrick tracks ongoing testing activity through 2026 across multiple products. Active testing cadence confirmed from public sources. No evidence of stale placeholder COAs. | 8/10 |
| Policy Transparency | 5 | Refund policy is publicly accessible but unusually restrictive: a quality-based claim requires the researcher to provide independent analytical data (HPLC or MS from a qualified third-party lab) demonstrating a purity discrepancy before Nexaph will review the claim. This shifts the evidentiary burden fully to the buyer. No standard return window for non-defective products. Contact email published (cain@nexaph.com). No company name, no registered entity, no founders named anywhere on the site. | 2/5 |
| Operational Track Record | 5 | Est. 2024. Approximately 2 years of operation. Fragmented operator identity: Finnrick's published analysis maps the vendor through a set of related domains and traces a corporate records trail described as "fragmented rather than a clean public counterparty." No registered entity, state of incorporation, or physical address publicly disclosed. | 1/5 |
| Total | 63/100 |